
Success Rate of Prostate Cancer Treatment in India
Filters & Insights
Written By :
Medically Reviewed By :
Dr. Tushar Aditya Narain
Uro-Oncology and Robotic Surgery
Prostate cancer remains one of the most common malignancies among men worldwide. However, advancements in robotic surgery, precision diagnostics, and modern oncological protocols have significantly improved treatment outcomes and survival rates. Over the last decade, India has rapidly emerged as one of the most trusted global destinations for prostate cancer treatment, especially for patients from the USA, UK, Middle East, Africa, Maldives, and Bangladesh.
According to leading international cancer guidelines such as the NCCN and the European Association of Urology, early detection combined with advanced treatment modalities plays a key role in improving outcomes. Indian hospitals follow these globally recognized protocols, which is one of the main reasons why the Success Rate of Prostate Cancer Treatment in India today is comparable to top centers in the US and Europe.
Prestigious multi-speciality hospitals such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare now offer cutting-edge technologies like da Vinci robotic surgery, IMRT/IGRT, CyberKnife radiosurgery, and PSMA PET-CT scans all of which contribute to improving the Success Rate of Prostate Cancer Treatment in India year after year.
This comprehensive guide explains in detail the Success Rate of Prostate Cancer Treatment in India, stage-wise outcomes, long-term survival rates, treatment options, costs, and the best hospitals and doctors for international patients. Whether you’re comparing treatment outcomes across countries or searching for a reliable hospital in India, this 2026 updated guide provides everything you need to make an informed decision.
What Makes India a Global Leader in Prostate Cancer Treatment?
India’s medical landscape has evolved rapidly, particularly in oncology. World-class robotic surgery systems, advanced imaging, standardized care protocols, and internationally trained doctors have placed India among the strongest global competitors.
Here are key advantages that influence treatment outcomes:
1. Cutting-Edge Technology
- da Vinci Xi Robotic Surgery Systems (latest generation)
- PET-CT, PSMA PET, and MRI fusion-guided biopsy
- CyberKnife & TrueBeam radiation systems
- Precision medicine tools
2. Highly Experienced Surgeons
Indian uro-oncologists have:
- 20–30 years of experience
- 2,000–10,000+ prostate surgeries performed
- International training from USA, UK, Germany & Canada
3. Multidisciplinary Tumor Boards
Teams combine the expertise of:
- Uro-oncologists
- Radiation oncologists
- Medical oncologists
- Radiologists
- Pathologists
- Rehabilitation specialists
4. Affordable Treatment Costs
Prostate cancer care in India costs 60–80% less than the U.S. or Europe, without compromising quality.
5. High Success Rates Comparable to the West
India’s success rates are in line with top global cancer centers, especially in:
- Early-stage prostate cancer
- Robotic prostatectomy outcomes
- Radiation therapy precision
Success Rate of Prostate Cancer Treatment in India

Success rates vary based on cancer stage, treatment modality, patient health, and tumor aggressiveness. Below is a safe, medically accurate summary based on international data ranges and India’s standardised outcomes.
1. Early-Stage Prostate Cancer (Stage I & II)
- Overall Success Rate: 85–98%
- 5-Year Survival Rate: 95–100%
- 10-Year Survival Rate: 85–95%
Early-stage prostate cancer especially localized, low-risk, or intermediate-risk disease is highly curable with timely treatment.
Most successful treatment options:
- Robotic radical prostatectomy (very high success rate)
- Intensity-Modulated Radiation Therapy (IMRT)
- CyberKnife Stereotactic Radiosurgery
- HIFU (selected patients)
2. Locally Advanced Prostate Cancer (Stage III)
- Overall Success Rate: 70–85%
- 5-Year Survival Rate: 70–85%
Treatment often requires a combination of:
- Surgery
- Radiation
- Hormone therapy
- Targeted therapies
India’s multidisciplinary oncology teams follow global protocols (NCCN, EAU) for improved outcomes.
3. Advanced or Metastatic Prostate Cancer (Stage IV)
- Overall Success Rate: Stabilization & life extension in 70–90% of patients
- 5-Year Survival Rate: Varies widely (based on spread & treatment response)
Modern therapies in India include:
- Hormone therapy (ADT)
- Chemotherapy
- PSMA-targeted therapy
- Immunotherapy & newer targeted agents
Although not curable, many patients live longer with good quality of life due to advanced medical care.
Success Rate by Treatment Type in India
Understanding each treatment’s success rate helps patients make informed decisions. These represent global benchmarks also followed in India.
1. Robotic Radical Prostatectomy (Robotic Surgery)
India is one of Asia’s top hubs for robotic prostate surgery, with extremely high success rates.
Success Rates
- Cancer control: 90–98% for localized disease
- Low recurrence rates
- Faster recovery time
- Better continence & sexual function outcomes compared to open surgery
Why robotic surgery is better:
- Highly precise removal of cancerous tissue
- Minimal bleeding
- Reduced hospital stay
- Reduced complications
India has 50+ advanced robotic centers.
2. Radiation Therapy (IMRT, IGRT, CyberKnife)
Success Rates:
- IMRT: 85–95% cancer control
- CyberKnife: Comparable to surgery in selected early-stage cases
- Proton therapy: Available in select centers
Radiation is ideal for:
- Patients who cannot undergo surgery
- Older men
- Early-stage or locally advanced disease
3. HIFU (High-Intensity Focused Ultrasound)
Success Rate:
- 70–90% for carefully selected early-stage patients
HIFU is non-invasive with very minimal side effects.
4. Hormone Therapy (ADT)
Success Rate:
- Effective in 70–90% of metastatic cases
- Significantly reduces cancer progression
Often combined with surgery or radiation.
5. Chemotherapy
Used for advanced prostate cancer.
Success Rate:
- Helps shrink tumors, prolong life, and improve symptoms
- Standardized global protocols used in India
6. Targeted Therapy & Immunotherapy
Newer agents like:
- Abiraterone
- Enzalutamide
- Sipuleucel-T
These improve survival and quality of life for advanced cancer patients.
Cost of Prostate Cancer Treatment in India
The cost of prostate cancer treatment in India depends on the cancer stage, risk category, recommended treatment approach, hospital, technology used and duration of care. Treatment expenses may differ significantly between patients because some require surgery or radiotherapy, while others need hormone therapy, chemotherapy or a combination of treatments.
Below are indicative treatment cost ranges in India for international patients:
1. Robotic Radical Prostatectomy
Estimated cost: USD 5,500–9,000
Robotic radical prostatectomy involves removing the prostate gland using a robotic-assisted surgical system. The final cost depends on the hospital, surgeon’s fees, length of admission, anaesthesia and post-operative care.
2. Intensity-Modulated Radiation Therapy (IMRT)
Estimated cost: USD 3,500–6,500
IMRT delivers precisely planned radiation to the prostate while limiting exposure to surrounding healthy tissues. The total expense depends on the treatment plan, number of sessions and radiation facility.
3. CyberKnife Radiosurgery
Estimated cost: USD 6,000–9,500
CyberKnife is a robotic radiation delivery system that may be used for selected prostate cancer cases. Suitability depends on the cancer’s stage, risk category and the treating radiation oncologist’s assessment.
4. High-Intensity Focused Ultrasound (HIFU)
Estimated cost: USD 4,500–7,500
HIFU uses focused ultrasound energy to destroy targeted prostate tissue. It is considered for selected patients, and its role depends on disease characteristics and clinical assessment. It is not a standard replacement for established treatments in every prostate cancer case.
5. Androgen Deprivation Therapy (ADT)
Estimated cost: USD 500–2,000 per treatment cycle
ADT reduces or blocks the effect of male hormones that can support prostate cancer growth. Costs vary according to the prescribed medicine, dosage, administration schedule and duration of treatment.
6. Chemotherapy
Estimated cost: USD 450–1,200 per session
Chemotherapy may be recommended for selected patients, particularly those with advanced or metastatic prostate cancer. The total cost depends on the medicines used, number of cycles, supportive medications and monitoring requirements.
7. Diagnostic Tests and Investigations
Estimated cost: USD 300–900
Diagnostic expenses may include:
- PSA blood testing
- Multiparametric MRI of the prostate
- Prostate biopsy and histopathology
- Selected blood investigations
- Additional imaging when clinically indicated
The investigations required depend on the patient’s symptoms, PSA level, examination findings and suspected disease stage.
Important Note About Prostate Cancer Treatment Costs
These figures are indicative estimates, not fixed hospital package prices. They may not include every consultation, medication, hospital stay, pathology test, complication-related expense or follow-up visit. Some treatments may also be combined, so their costs should not automatically be added together.
Patients should request an individualised, itemised estimate from the treating hospital after medical evaluation. The final treatment plan and cost depend on the diagnosis, cancer risk category, overall health and specialist recommendations.
International patients typically save 60–70% compared to the USA, UK, UAE, and Europe.
Factors That Affect Prostate Cancer Treatment Outcomes in India
The outcomes of prostate cancer treatment depend on several clinical and treatment-related factors. These include the stage and grade of the cancer, PSA level, tumour characteristics, the treatment approach and the patient’s overall health. The experience of the treating medical team and regular follow-up also play important roles in long-term disease management.
1. Cancer Stage at Diagnosis
The stage of prostate cancer is one of the most important factors influencing treatment outcomes. Cancer confined to the prostate generally has more treatment options and a more favourable prognosis than cancer that has spread to lymph nodes or distant organs. Early diagnosis allows specialists to assess suitable options, which may include active surveillance, surgery or radiation therapy.
2. Gleason Score and Grade Group
The Gleason score and Grade Group help doctors understand how aggressive prostate cancer cells appear under a microscope. Lower-grade cancers generally grow more slowly, while higher-grade cancers may behave more aggressively and require closer monitoring or more intensive treatment. These findings help specialists determine the appropriate treatment strategy alongside PSA levels and cancer stage.
3. Choice of Treatment and Individual Suitability
Treatment outcomes depend on selecting an approach that matches the patient’s cancer risk category, age, overall health and personal preferences. Options may include active surveillance, radical prostatectomy, radiation therapy, hormone therapy or a combination of treatments.
Robotic-assisted surgery and modern radiation techniques can offer important advantages for appropriately selected patients. However, neither approach guarantees higher cancer-control rates for every patient. Treatment selection should be based on clinical evidence and specialist assessment.
4. Experience of the Surgeon and Hospital
The experience of the treating team and the hospital’s ability to provide comprehensive prostate cancer care can influence treatment quality and recovery. Patients may consider:
- The surgeon’s experience with prostate cancer procedures
- Hospital experience in managing complex prostate cancer cases
- Availability of advanced imaging and diagnostic facilities
- Access to medical oncology and radiation oncology specialists
- Post-operative care and rehabilitation services
Multidisciplinary evaluation is particularly important when treatment involves more than one speciality.
5. Patient’s Overall Health and Medical History
Age, general fitness, existing medical conditions and baseline urinary and sexual function can influence treatment suitability, recovery and the risk of complications. A younger patient does not automatically have better cancer outcomes than an older patient. Doctors assess overall health and life expectancy when recommending treatment.
6. Post-Treatment Follow-up and PSA Monitoring
Regular follow-up is essential after prostate cancer treatment. PSA testing helps doctors monitor the response to treatment and identify possible signs of biochemical recurrence. The frequency and interpretation of PSA tests depend on the treatment received and the patient’s clinical history.
After radical prostatectomy, PSA is generally expected to fall to very low or undetectable levels. After radiation therapy, PSA usually declines more gradually, so follow-up results are interpreted differently.
Following the recommended PSA monitoring and follow-up guidelines helps specialists assess treatment response, identify changes early and plan further care when required.
How Shifam Health Helps International Patients
Shifam Health works as a trusted healthcare guidance platform and hospital partner, offering:
● Treatment planning
● Hospital selection
● Doctor appointments
● Medical reports assessment
● Cost comparison
● Visa assistance
● Airport pickup & travel coordination
● On-ground patient support
Important Read: India Medical Visa 2026: New Rules, Application Process & FAQs
Conclusion
India has become a global hub for prostate cancer treatment, offering:
- High survival rates
- Advanced robotic surgery
- Leading oncologists
- Low complication rates
- Affordable treatment packages
- Comprehensive international patient support
Whether you’re at the beginning of your diagnosis or seeking a second opinion, India provides some of the best outcomes worldwide.
Frequently Asked Questions (FAQs)
India’s prostate cancer treatment success rates range from 85–98% for early-stage cases, comparable with the USA and Europe.
Yes — over 50+ hospitals offer da Vinci robotic prostatectomy.
Depending on the treatment, costs range from $300 to $9,500 USD.
Yes — most follow NCCN, EAU, and global oncology protocols.
Yes — Shifam Health provides visa assistance, airport pickup, translator support, and more.
| Take the First Step It costs Nothing Share your medical reports with Shifam Health and receive a free, personalized assessment within 24 hours. No commitment. No pressure. Just honest information to help you make the right decision for you and your family. www.shifamhealth.com | contact@shifamhealth.com | WhatsApp: +91 81785 95807 24/7 Support Available | Free Consultation | No Hidden Charges |
Popular Posts From Last Week
- November 21, 2026
- Razi Khan
- November 20, 2026
- Razi Khan
- November 19, 2026
- Razi Khan
- November 19, 2026
- Razi Khan
- November 19, 2026
- Shifam Health
- November 18, 2026
- Shifam Health
- November 18, 2026
- Razi Khan
- November 18, 2026
- Razi Khan
- November 17, 2026
- Razi Khan
- November 17, 2026
- Razi Khan
- November 16, 2026
- Shifam Health
- November 17, 2026
- Razi Khan


